Assistant Director of Drug Development

Judy Wang, MD is Lead Author of Manuscript Detailing Investigational Treatment to Improve Immunotherapy Outcomes for Patients with Advanced Cancers

CERo Therapeutics Progresses Phase 1 CER-1236 AML Trial with Dosing of Third Patient in Initial Dose Cohort

Florida Cancer Specialists & Research Institute Clinical Expertise And Real-World Evidence Capabilities Advancing Treatment of Blood Cancers

Veeva MedTech adoption boosts clinical trials

Director, Application Engineering

Sarah Cannon Research Institute (SCRI) is a leading oncology research organization dedicated to advancing cancer treatments. The Director of Application Engineering will oversee the management of engineering and operational processes for various applications, ensuring alignment with SCRI’s digital strategy and collaboration with external partners.

Sign up with Google

Sign in with Google